Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): A randomised, double-blind, placebo-controlled trial

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 10, 2015, Pages 778-786

  Chiswick, Carolyn ^a   Reynolds, Rebecca M ^b   Denison, Fiona ^a   Drake, Amanda J ^b   Forbes, Shareen ^b   Newby, David E ^c   Walker, Brian R ^b   Quenby, Siobhan ^d   Wray, Susan ^e   Weeks, Andrew ^e   Lashen, Hany ^f   Rodriguez, Aryelly ^g   Murray, Gordon ^g   Whyte, Sonia ^a   Norman, Jane E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^f JESSOP HOSPITAL FOR WOMEN   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METFORMIN; PLACEBO; ANTIDIABETIC AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BODY MASS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG TOLERABILITY; EFFECT SIZE; FEMALE; FETUS OUTCOME; FLATULENCE; FOLLOW UP; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEADACHE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL OBESITY; NAUSEA; NEWBORN DEATH; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SPONTANEOUS ABORTION; STILLBIRTH; TASTE DISORDER; UNITED KINGDOM; VOMITING; ABORTION, SPONTANEOUS; DIABETES, GESTATIONAL; DOUBLE BLIND PROCEDURE; FETAL MACROSOMIA; OBESITY, ABDOMINAL; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADULT; DIABETES, GESTATIONAL; DOUBLE-BLIND METHOD; FEMALE; FETAL MACROSOMIA; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; OBESITY, ABDOMINAL; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; STILLBIRTH; YOUNG ADULT;

EID: 84941806154     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00219-3     Document Type: Article

References (31)

1. O'Brien TE, Ray JG, Chan WS Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003, 14:368-374.
2. Johansson S, Villamor E, Altman M, Bonamy AK, Granath F, Cnattingius S Maternal overweight and obesity in early pregnancy and risk of infant mortality: a population based cohort study in Sweden. BMJ 2014, 349:g6572.
3. Heslehurst N, Simpson H, Ells LJ, et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev 2008, 9:635-683.
4. Starling AP, Brinton JT, Glueck DH, et al. Associations of maternal BMI and gestational weight gain with neonatal adiposity in the Healthy Start study. Am J Clin Nutrit 2015, 101:302-309.
5. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996, 94:3246-3250.
6. Curhan GC, Chertow GM, Willett WC, et al. Birth weight and adult hypertension and obesity in women. Circulation 1996, 94:1310-1315.
7. Parsons TJ, Power C, Logan S, Summerbell CD Childhood predictors of adult obesity: a systematic review. Int J Obes Relat Metab Disord 1999, 23(suppl 8):S1-107.
8. Graversen L, Sorensen TI, Gerds TA, et al. Prediction of adolescent and adult adiposity outcomes from early life anthropometrics. Obesity 2015, 23:162-169.
9. Surkan PJ, Hsieh CC, Johansson AL, Dickman PW, Cnattingius S Reasons for increasing trends in large for gestational age births. Obstet Gynecol 2004, 104:720-726.
10. Reynolds RM, Allan KM, Raja EA, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1323275 person years. BMJ 2013, 347:f4539.
11. Catalano PM, Ehrenberg HM The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG 2006, 113:1126-1133.
12. Scholl TO, Sowers M, Chen X, Lenders C Maternal glucose concentration influences fetal growth, gestation, and pregnancy complications. Am J Epidemiol 2001, 154:514-520.
13. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002.
14. Eames AJ, Grivell RM, Deussen AR, Hague W, Dodd JM Metformin for women who are obese during pregnancy for improving maternal and infant outcomes. Cochrane Database Syst Rev 2013, 6. CD010564.
15. Chiswick CA, Reynolds RM, Denison FC, et al. Efficacy of metformin in pregnant obese women: a randomised controlled trial. BMJ Open 2015, 5:e006854.
16. Boney CM, Verma A, Tucker R, Vohr BR Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115:e290-e296.
17. Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682. International Association of Diabetes Pregnancy Study Groups Consensus Panel.
18. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007, 92:969-975.
19. Bonellie S, Chalmers J, Gray R, Greer I, Jarvis S, Williams C Centile charts for birthweight for gestational age for Scottish singleton births. BMC Pregnancy Childbirth 2008, 8:5.
20. Thangaratinam S, Rogozinska E, Jolly K, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ 2012, 344:e2088.
21. Dodd JM, Cramp C, Sui Z, et al. The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on maternal diet and physical activity: the LIMIT randomised trial. BMC Med 2014, 12:161. for the Limit Randomised Trial Group.
22. Poston L, Bell R, Croker H, et al. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 2015, published online July 10. http://dx.doi.org/10.1016/S2213-8587(15)00227-2.
23. Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010, 95:E448-E455.
24. Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 2007, 166:1312-1319.
25. Xu L, Lee M, Jeyabalan A, Roberts JM The relationship of hypovitaminosis D and IL-6 in preeclampsia. Am J Obstet Gynecol 2014, 210:149. e1-7.
26. Goldberg RB, Temprosa MG, Mather KJ, Orchard TJ, Kitabchi AE, Watson KE Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes. Diabetes Care 2014, 37:2253-2260. Diabetes Prevention Program Research Group.
27. Xu X, Du C, Zheng Q, Peng L, Sun Y Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review. BMC Womens Health 2014, 14:93.
28. Pedersen J Diabetes and pregnancy: blood sugar of newborn infants 1952, Danish Science Press, Copenhagen.
29. Catalano PM, Hauguel-De Mouzon S Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?. Am J Obstet Gynecol 2011, 204:479-487.
30. Salomaki H, Heinaniemi M, Vahatalo LH, et al. Prenatal metformin exposure in a maternal high fat diet mouse model alters the transcriptome and modifies the metabolic responses of the offspring. PLoS One 2014, 9:e115778.
31. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008, 358:2003-2015.